The global viral clearance service market was valued at US$ 261.9 Mn in 2017 and is anticipated to reach US$ 902.1 Mn by 2026, expanding at a CAGR of 14.9% from 2018 to 2026. Increase in demand for detection of virus removal/inactivation in products during their early stages of development, rise in R&D expenditure, growing preference for outsourcing of viral clearance service to contract research organizations, rise in consumer awareness about safety associated with the use of health care and vaccines, and increase in concern of viral effects of blood-derived products are some factors boosting the demand for viral clearance service.

Source: Click here